Radiological Society of North America (RSNA) 2022 will kick off its five-day run at the McCormick Place Convention Center in Chicago, Ill., from Nov. 27 to Dec. 1. The conference will provide both in-person and virtual participation.RSNA is the world’s largest academic society consisting of over 48,
ImmuneMed has won the approval for the domestic clinical trial of its candidate substance for a Covid-19 cure, hzVCFG-v13 (burfiralimab).Last Friday, the Ministry of Food and Drug Safety gave the go-ahead to Korea's phase 2/3 clinical trial. The company plans to assess the efficacy and safety of the
Korea hit yet another Covid-19 related grim milestone as the total Covid-19 deaths surpassed 30,000 on Sunday.According to the Central Disease Control Headquarters, the cumulative number of deaths from Covid-19 reached 30,031 on Sunday, exceeding 30,000.The death toll reached 30,000 in about seven m
A research team at Yonsei University College of Medicine said it identified the relationship between the expression level of proteins involved in the movement of substances within cells and the severity of atopic dermatitis.The research team, led by Professors Nam Ki-teak and Park Chang-wook at the
Lunit said on Monday that it became the first software as a medical device (SaMD) company in the Asia Pacific region to earn accreditations from the UK and Europe for its artificial intelligence (AI) medical solutions.Both Lunit INSIGHT CXR and Lunit INSIGHT MMG, an AI solution for chest radiology a
As the Covid-19 pandemic weakens to an endemic, the global medical tourism industry will restore its growth momentum from 2023, a report said.According to the report, the global medical tourism industry had grown rapidly since the turn of the 2000s but fell into a slump in 2020 due to the outbreak o
Yuyu Pharmaceutical unveiled its plans to conduct U.S. and EU clinical trials for using dutasteride to treat androgenetic alopecia (AGA) during the World Congress for Hair Research 2022 held in Melbourne, Australia, from Friday to Monday.The trial aims to improve patient convenience by reducing the
Lilly Korea said on Monday that its CDK 4&6 inhibitor Verzenio (ingredient: abemaciclib) has been approved by the Ministry of Food and Drug Safety (MFDS) on Friday for an additional indication for high-risk early breast cancer.Specifically, it was approved for hospital patients with a high risk of r
Moderna started to receive recognition as a messenger RNA (mRNA) powerhouse after developing an effective Covid-19 vaccine less than a year after the Covid-19 pandemic first started.However, with the Covid-19 pandemic becoming more of an endemic than a pandemic, both industry watchers and investors
The government said it plans to stop using Moderna's monovalent Covid-19 vaccine from next month."The expiration date of the currently introduced Moderna's monovalent vaccine is Dec. 16, and we plan to stop using the vaccine in consideration of the public's demand," the Covid-19 vaccination response
The wide gap in infection control between large general hospitals and smaller medical institutions remains unchanged, according to government data.For instance, the rate of tertiary hospitals that operate infection control offices was 100 percent, but the comparable rate for smaller hospitals with 1
The news -- that Nicholas Volker, a 6-year-old American patient with a rare disease, was first diagnosed based on advanced genomic technology -- made headlines in the genetic diagnosis academia and industry in 2011. It was then that I first learned about the problem of diagnosing rare diseases. But
Korean conglomerates are jumping into the bio-industry after seeing success from predecessors, including Samsung and SK.Most recently, Orion Holdings, the holding company of the Orion Group, decided to start the bio business in earnest by establishing Orion Biologics.In a public filing, Orion Holdin
JW Pharmaceutical said on Friday that its oral renal anemia drug, Enaroy (ingredient: enarodustat), obtained license approval from the Ministry of Food and Drug Safety (MFDS).Renal anemia is one of the complications of chronic kidney disease, and is caused by poor differentiation and proliferation o
Celltrion has won new “domestic” approval for a Humira (adalimumab) biosimilar with the same dosage and formulation as the currently marketed product, drawing the industry’s attention to the reason.According to the Ministry of Food and Drug Safety, Celltrion obtained domestic approval for Yuflyma Pe
Celltrion said on Friday that it won the first trial of two patents (Patent No. US 9254338, US 9669069) against Regeneron, a leading biotechnology company in the United States.The lawsuit regards a U.S. patent on the treatment of angiogenic ophthalmic diseases of Eylea (ingredient: aflibercept), an
Researchers at Severance Hospital have identified the risk of developing diabetes using immunotherapy.Immunotherapies are drugs that prevent cancer cells from evading the body's immune system, allowing immune cells to better recognize and attack cancer cells.After the first immunotherapy agent recei
“Korean biotechnology companies’ scientific quality does not lag behind other countries. However, they fall somewhat short of understanding what the medical community and biotech industry want.”So said Philip Tagari, vice chair for Amgen’s R&D, who visited Korea to attend the “Second KHIDI-AMGEN Sci
A government survey showed that patients who tried telemedicine during the Covid-19 pandemic are highly satisfied, with almost nine out of 10 users responding that they would continue using non-contract treatment.The Korea Health Industry Development Institute (KHIDI) released the results of its sur
To help foster healthcare startups, BMS Korea held the “Seoul BMS Innovation Square Challenge” award ceremony with the Seoul Municipal Government and the Korea Health Industry Development Institute (KHIDI) at Seoul Bio Hub last week.The challenge is an open innovation partnering program pushed joint